These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5760937)

  • 1. [State of the endometrium in leprosy].
    Vishnevskaia LG; Bogush TG
    Akush Ginekol (Mosk); 1968 Aug; 44(8):64-8. PubMed ID: 5760937
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical stages in sulfone treatment of leprosy.
    Rodriguez JN
    Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow up study of thirty-six borderline cases of leprosy.
    Kundu S; Ghosh S
    Bull Calcutta Sch Trop Med; 1967 Jul; 15(3):103-4. PubMed ID: 5616299
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-induced pathomorphosis of skin lesions in leprosy].
    Vishnevetskiĭ FE
    Arkh Patol; 1971; 33(9):70-7. PubMed ID: 4336757
    [No Abstract]   [Full Text] [Related]  

  • 5. Reappraisal of functional and structural changes in liver in leprosy.
    Gupta MC; Kumar S; Tyagi SP
    J Assoc Physicians India; 1974 Jan; 22(1):13-8. PubMed ID: 4844724
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 7. Histoid leprosy.
    Sehgal VN; Srivastava G
    Int J Dermatol; 1985 Jun; 24(5):286-92. PubMed ID: 3894259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunomorphology of lepromatous leprosy].
    Kop'eva TN
    Arkh Patol; 1972; 34(4):35-41. PubMed ID: 5043685
    [No Abstract]   [Full Text] [Related]  

  • 9. The histoid leproma. Its characteristics and significance.
    Rodriguez JN
    Int J Lepr Other Mycobact Dis; 1969; 37(1):1-21. PubMed ID: 5817631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic and histomorphologic features of responsiveness in patients with leprosy at different stages of treatment].
    Strukov AI; Babaiants RS; Shakhtmeĭster IIa; Kopieva TN; Goloschapov NM
    Vestn Dermatol Venerol; 1972 Oct; 46(10):8-12. PubMed ID: 4569353
    [No Abstract]   [Full Text] [Related]  

  • 11. Leprosy and female reproductive organs.
    Sharma SC; Kumar B; Dhall K; Kaur S; Malhotra S; Aikat M
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):177-9. PubMed ID: 7196887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy.
    Jacobson RR; Trautman JR
    Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221
    [No Abstract]   [Full Text] [Related]  

  • 13. The promin treatment of leprosy. A progress report.
    Faget GH; Pogge RC; Johansen FA; Dinan JF; Prejean BM; Eccles CG
    Int J Lepr Other Mycobact Dis; 1966; 34(3):298-310. PubMed ID: 5950351
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of leprosy by sulfones and delayed action sulfonamides. Comparison of therapeutic results in 100 cases].
    Faye I; Privat Y; Bellossi A
    Bull Soc Med Afr Noire Lang Fr; 1968; 13(1):119-24. PubMed ID: 5713742
    [No Abstract]   [Full Text] [Related]  

  • 15. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases].
    Privat Y; Faye I; Bellossi A
    Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leprosy].
    Languillon J
    Acta Leprol; 1978; (71-72):1-168. PubMed ID: 104538
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro immunologic changes in 4 patients with lepromatous leprosy treated for 1 year with rifampicin and sulfones and left untreated the following year].
    Saint-André P
    Acta Leprol; 1979; (76-77):301-2. PubMed ID: 121849
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintenance of leprosy endemicity and bacterial positivity of lepromatous patients under treatment with sulfones.
    Bechelli LM; Dominguez VM
    Int J Lepr Other Mycobact Dis; 1971; 39(2):461. PubMed ID: 5169809
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on sulfone resistance in leprosy. I. Detection of cases.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.